Clinical Trial Update: Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on using monosialotetrahexosylganglioside sodium injection to prevent neurotoxicity from mFOLFOX 6 in advanced gastric cancer. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Monosialotetrahexosylganglioside Sodium Injection (monosialotetrahexosylganglioside sodium)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN